Full Text

Turn on search term navigation

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

The changes in the stable isotope ratios of carbon (δ13C), nitrogen (δ15N), oxygen (δ18O), and mercury (Hg) concentrations in muscle and liver tissues during and after lactation were studied in killer whales stranded along the coast of Hokkaido, in the northern area of Japan (n = 16). Calf muscles displayed δ13C- and δ15N-enriched peaks and a δ18O-depleted peak during lactation. The δ13C- and δ15N-enriched peaks appear to reflect the extensive nursing of 13C- and 15N-enriched milk and the onset of weaning, whereas the δ18O-depleted peak may be attributable to the extensive nursing of 18O-depleted milk and the onset of weaning. The δ13C and δ15N values tended to gradually increase after the weaning, whereas the δ18O values tended to decrease. The δ13C and δ15N levels in calves were similar between liver and muscle samples, whereas those in mature animals were higher in liver than in muscle samples. The isotopic turnover rates of C and N may be similar between the liver and muscle tissues in calves, which are rapidly growing animals. The Hg concentrations in muscle tissues were slightly higher in small calves than in large calves, probably due to the Hg transfer across placenta. The Hg concentrations in liver and muscle samples increased with increasing body length, and those in two liver samples from mature animals exceeded the high-risk threshold for marine mammal health effects (82 μg/wet g).

Details

Title
Changes in Carbon, Nitrogen, and Oxygen Stable Isotope Ratios and Mercury Concentrations in Killer Whales (Orcinus orca) during and after Lactation
Author
Endo, Tetsuya 1 ; Kimura, Osamu 1 ; Terasaki, Masaru 1   VIAFID ORCID Logo  ; Kato, Yoshihisa 2   VIAFID ORCID Logo  ; Fujii, Yukiko 3   VIAFID ORCID Logo  ; Haraguchi, Koichi 3 

 School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, 1757, Ishikari-Tobetsu, Hokkaido 061-0293, Japan; [email protected] (O.K.); [email protected] (M.T.) 
 Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Sanuki 769-2193, Japan; [email protected] 
 Department of Pharmaceutical Sciences, Daiichi University of Pharmacy, Minami-ku, Fukuoka 815-8511, Japan; [email protected] (Y.F.); [email protected] (K.H.) 
First page
623
Publication year
2024
Publication date
2024
Publisher
MDPI AG
e-ISSN
20771312
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3046967717
Copyright
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.